Corvus Pharmaceuticals Overview
Corvus Pharmaceuticals Target Price
Analysts' 12-month price predictions for CRVS.
Get informed when a big investor buys or sells
+ FollowShare Price
$12.63
Average Target Price
$40.00
216.7% upside
216.7% upside1 analysts in the last 4 months
High: $40 | Low: $40
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-04-17 | Goldman Sachs | $40 | 216.7% upside |  |
| 2026-01-29 | Mizuho SecuritiesGraig Suvannavejh | $30 | 137.5% upside | |
| 2026-01-22 | JefferiesRoger Song | $42 | 232.5% upside | |
| 2026-01-21 | Oppenheimer | $32 | 153.4% upside | |
| 2026-01-20 | Barclays | $28 | 121.7% upside | |
| 2026-01-20 | Mizuho Securities | $20 | 58.4% upside | |
| 2026-01-20 | H.C. WainwrightSean Lee | $27 | 113.8% upside | |
| 2025-10-29 | Mizuho Securities | $13 | 2.9% upside | |
| 2025-10-13 | Barclays | $16 | 26.7% upside | |
| 2025-05-20 | Mizuho SecuritiesGraig Suvannavejh | $11 |  12.9% downside | |
| 2024-11-13 | JefferiesRoger Song | $13 | 2.9% upside | |
| 2024-10-22 | Mizuho SecuritiesGraig Suvannavejh | $12 | 5% downside | |
| 2023-08-18 | OppenheimerJeff Jones | $7 | 44.6% downside | |